Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
-
NEW YORK, 30 juill. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome...
-
Omada Health announced it will release its second quarter 2026 results on Thursday, August 6, 2026, after market close.
-
Dynacor Group Inc. announces its unaudited financial and operational results for the first quarter ended March 31, 2026.
-
MONTRÉAL, 14 mai 2026 (GLOBE NEWSWIRE) -- Groupe Dynacor inc. (TSX : DNG) (« Dynacor » ou la « Société ») a annoncé aujourd’hui ses résultats financiers et opérationnels1 non audités pour le...
-
Omada Health Reports First Quarter 2026 Results
-
Omada Health Reports Fourth Quarter and Full-Year 2025 Results
-
Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026
-
Dynacor Group Inc. announces preliminary fourth-quarter and full-year 2025 operating results and its 2026 outlook.
-
MONTRÉAL, 19 janv. 2026 (GLOBE NEWSWIRE) -- Groupe Dynacor inc. (TSX : DNG) (« Dynacor » ou la « Société ») est heureuse d'annoncer ses résultats d'exploitation préliminaires pour le quatrième...